Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ofosu

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Canadian Journal of Biochemistry|June 1, 1971
Hemoglobin binding by enzymatic fragments of haptoglobinF Ofosu, G E Connell
Seminars in Thrombosis and Hemostasis|January 1, 1985
Rationale behind the development of low molecular weight heparin derivativesJ Hirsh, F Ofosu, M Buchanan
Biochimica Et Biophysica Acta|November 1, 1978
Mucin degradation in the intestineF Ofosu, J Forstner, G Forstner
Thrombosis Research|November 15, 1980
The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin-IIIF Ofosu, M A Blajchman, J Hirsh
Wiener Klinische Wochenschrift|January 1, 1993
Prevention and treatment of thrombosis: novel strategies arising from our understanding the healthy endotheliumM R Buchanan, S J Brister, F Ofosu
Analytical Biochemistry|December 1, 1977
Radioimmunoassay of intestinal goblet cell mucinJ F Forstner, F Ofosu, G G Forstner
The Journal of Laboratory and Clinical Medicine|November 1, 1988
Standard assays underestimate the concentration of heparin in neonatal plasmaB Schmidt, L Mitchell, F Ofosu, et al.
Thrombosis and Haemostasis|December 1, 1994
Thrombin regulation in children differs from adults in the absence and presence of heparinM Andrew, L Mitchell, P Vegh, et al.
Thrombosis Research|July 1, 1991
Heparin sensitivity and resistance in the neonate: an explanationA Vieira, L Berry, F Ofosu, et al.
Blood|November 1, 1991
Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient childrenL Mitchell, F Piovella, F Ofosu, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Canadian Journal of Biochemistry|June 1, 1971
Hemoglobin binding by enzymatic fragments of haptoglobinF Ofosu, G E Connell
Seminars in Thrombosis and Hemostasis|January 1, 1985
Rationale behind the development of low molecular weight heparin derivativesJ Hirsh, F Ofosu, M Buchanan
Biochimica Et Biophysica Acta|November 1, 1978
Mucin degradation in the intestineF Ofosu, J Forstner, G Forstner
Thrombosis Research|November 15, 1980
The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin-IIIF Ofosu, M A Blajchman, J Hirsh
Wiener Klinische Wochenschrift|January 1, 1993
Prevention and treatment of thrombosis: novel strategies arising from our understanding the healthy endotheliumM R Buchanan, S J Brister, F Ofosu
Analytical Biochemistry|December 1, 1977
Radioimmunoassay of intestinal goblet cell mucinJ F Forstner, F Ofosu, G G Forstner
The Journal of Laboratory and Clinical Medicine|November 1, 1988
Standard assays underestimate the concentration of heparin in neonatal plasmaB Schmidt, L Mitchell, F Ofosu, et al.
Thrombosis and Haemostasis|December 1, 1994
Thrombin regulation in children differs from adults in the absence and presence of heparinM Andrew, L Mitchell, P Vegh, et al.
Thrombosis Research|July 1, 1991
Heparin sensitivity and resistance in the neonate: an explanationA Vieira, L Berry, F Ofosu, et al.
Blood|November 1, 1991
Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient childrenL Mitchell, F Piovella, F Ofosu, et al.
Pageof 4